Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02126670 · ClinicalTrials.gov registry record · Phase 2
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
A Phase 2 study, sponsored by Promius Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT02126670: Completed Phase 2 study, sponsored by Promius Pharma.
NCT02126670 is a Phase 2 study that has completed, run by Promius Pharma. The registered enrollment target is 100 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02126670, a Phase 2 study, has completed, sponsored by Promius Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether or not ACT01 is effective and tolerable alone or when used in combination with Comp01, Comp02, Comp03 or Comp04 in patients with facial and/or scalp keratosis.
Primary Outcome
Treatment success at end of study visit defined as % of participants with 100% clearance of AK lesions
Interventions
- DRUG ACT01
- DRUG Comp01
- DRUG Comp02
- DRUG Comp03
- DRUG Comp04
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
What the finished NCT02126670 record still lists
NCT02126670 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower).
The record links to 0 conditions, and to 5 interventions - of which ACT01 is the first listed.
NCT02126670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02126670 about?
NCT02126670 is a clinical study titled "ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis". The purpose of this study is to determine whether or not ACT01 is effective and tolerable alone or when used in combination with Comp01, Comp02, Comp03 or Comp04 in patients with facial and/or scalp keratosis.
What is the current status of trial NCT02126670?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2014-04. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02126670?
The interventions under investigation include: ACT01 (DRUG), Comp01 (DRUG), Comp02 (DRUG), Comp03 (DRUG), Comp04 (DRUG).
Who is sponsoring clinical trial NCT02126670?
This trial is sponsored by Promius Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02126670's enrollment target sits among peer trials
100 672nd of 2000 higher than 1,263 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia